食管癌患者CT上T12/L3椎体水平的身体成分及其与生存的相关性
本研究回顾性分析206例接受放化疗的II-IV期食管鳞癌患者的405人次CT,比较T12与L3椎体水平身体成分指标的相关性及其对生存的影响。T12与L3各指标呈显著相关(SMI的Spearman系数0.62),校正后低T12骨骼肌指数与总生存期缩短显著相关(校正HR=1.56,p=0.04),与低L3骨骼肌指数对应(校正HR=1.65,p=0.04)。结论认为T12测量可有效诊断肌少症并作为预后指标。
要点
- T12与L3身体成分指标显著相关,SMI的Spearman系数为0.62。
- 低T12骨骼肌指数与总生存期缩短显著相关(校正HR=1.56,p=0.04)。
- 仅胸部CT即可在T12评估肌少症并预测食管鳞癌患者生存。
核心结论
- 测量T12骨骼肌可有效诊断肌少症并利用仅胸部CT完成评估,放化疗后T12骨骼肌指数可能作为食管鳞癌患者的预后指标。
研究设计与样本
- 回顾性分析206例II-IV期接受放化疗的食管鳞癌患者的405人次CT,在T12和L3椎体水平测量身体成分指标并与临床结局比较。
诊断标准与关键数值
- T12与L3身体成分参数显著相关,SMI的Spearman系数0.62、SMA为0.72、IMAC为0.59、VSR为0.46(均p<0.01);校正年龄、性别和肿瘤分期后,低放化疗后T12 SMI与总生存期缩短显著相关(校正HR=1.56,p=0.04),对应低放化疗后L3 SMI(校正HR=1.65,p=0.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study examined whether CT metrics at the 12th thoracic vertebra (T12) can replace those at the 3rd lumbar vertebra (L3) for diagnosing sarcopenia, and analyzed their impact on outcomes in esophageal squamous cell carcinoma (ESCC).
MATERIALS AND METHODS: We retrospectively reviewed 405 CT scans (person-times) of 206 ESCC patients (stages II-IV) who had received chemoradiotherapy (CRT). Metrics including Skeletal Muscle Index (SMI), Skeletal Muscle Attenuation (SMA), Intramuscular Adipose Content (IMAC), and Visceral-to-Subcutaneous Adipose Tissue Ratio (VSR) were measured at both T12 and L3. These were compared with clinical outcomes.
RESULTS: Significant correlations were found between body composition parameters measured at T12 and L3, with Spearman's coefficients of 0.62 for SMI, 0.72 for SMA, 0.59 for IMAC, and 0.46 for VSR (all p < 0.01). After adjusting for age, gender, and tumor stage, a low post-CRT T12 SMI was significantly associated with reduced overall survival (adjusted hazard ratio = 1.56, p = 0.04), which corresponded to low post-CRT L3 SMI (adjusted hazard ratio = 1.65, p = 0.04).
CONCLUSIONS: We concluded that measuring skeletal muscle at T12 can effectively diagnose sarcopenia using chest-only CT scans. Post-CRT T12 SMI may serve as a prognostic indicator for ESCC patients.
KEY POINTS: Question Assessing sarcopenia in esophageal cancer patients is crucial for prognosis, yet traditional metrics rely on the 3rd lumbar vertebra, which may not be optimal. Findings Our study demonstrates that the muscle index at the 12th thoracic vertebra correlates well with that of the 3rd lumbar vertebra, effectively predicting patient survival. Clinical relevance Evaluating sarcopenia at the 12th thoracic vertebra via chest CT offers a reliable prognostic tool for esophageal squamous cell carcinoma patients, potentially improving survival predictions after chemoradiotherapy.
引用
- Huang YL, Wu CC, Chou IT, et al. Body components at T12/L3 on CT and correlation with survival in esophageal cancer. Eur Radiol. 2025. PMID: 40760116. doi:10.1007/s00330-025-11854-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。